Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54)

The summary for the Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54): -Purpose. This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH), solicits grant applications from institutions/organizations for the creation of Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) Nodal Centers to conduct comprehensive translational/basic and clinical research in pediatric therapeutics. A major goal of the PPTRC Nodal Centers will be to conduct research that will fill gaps in knowledge that may be responsible for failed efficacy trials or that may prevent Food and Drug Administration (FDA) labeling of drugs in pediatrics. In addition, the Consortium will be expected to adopt a new paradigm of promoting personalized pediatric therapeutics and promote a greater understanding of the interrelationship among disease processes, and therapy across the developmental spectrum. Testing of new molecular entities, pediatric formulations, novel therapeutic approaches, new types of delivery systems and development and testing of biomarkers will be priorities for the consortium. Each application will have a translational, a pharmacometric and a clinical research core in addition to an administrative unit. Individual PPTRC Nodal Centers must involve collaborating investigators at two or more different institutions.The Consortium will also be a locus of training future leaders and researchers in pediatric clinical and developmental pharmacology. -Mechanism of Support. This FOA will utilize the U54 grant mechanism. -Funds Available and Anticipated Number of Awards. The total amount of funding that the NICHD expects to award through this announcement is approximately $ 9.5 million for FY 2010. Up to seven PPTRC Nodal Centers awards are expected from this solicitation.

Federal Grant Title:	Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Income Security and Social Services Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-08-021
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.865
CFDA Descriptions:	Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Mar 31, 2009
Posted Date:	Oct 21, 2008
Creation Date:	Nov 17, 2008
Archive Date:	Dec 05, 2008
Total Program Funding:	$9,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...; • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...; • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...; • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed); • Biological Testing Facility (X01 Clinical Trial Not Allowed); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...